Arteriosclerosis, Thrombosis, and Vascular Biology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 8.8 | Q1 | 93.0% | 2.884 | Q1 | 97.5% |
| 2024 | 7.4 | Q1 | 92.9% | 2.532 | Q1 | 97.0% |
| 2023 | 7.4 | Q1 | 94.7% | 2.582 | Q1 | 97.1% |
| 2022 | 8.7 | Q1 | 94.4% | 2.798 | Q1 | 97.7% |
| 2021 | 10.5 | Q1 | 94.2% | 2.679 | Q1 | 97.6% |
| 2020 | — | — | 3.007 | Q1 | 97.8% | |
| 2019 | — | — | 2.721 | Q1 | 97.4% | |
| 2018 | — | — | 2.771 | Q1 | 97.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1524-4636
ISSN
1079-5642
region
Northern America
coverage
1990-2026